Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture.

× No keyword cloud information.

23 in total

1. Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects.

Authors: Manfred Schmitt; Karin Mengele; Apostolos Gkazepis; Rudolf Napieralski; Viktor Magdolen; Ute Reuning; Nadia Harbeck
Journal: Breast Care (Basel) Date: 2008-10-15 Impact factor: 2.860

2. Kinetic analysis of the effects of glycosaminoglycans and lipoproteins on urokinase-mediated plasminogen activation.

Authors: J M Edelberg; M Weissler; S V Pizzo
Journal: Biochem J Date: 1991-06-15 Impact factor: 3.857

3. Development and characterization of a human cell line from an ovarian mixed Müllerian tumor (carcinosarcoma).

Authors: C van Haaften-Day; P Russell; S Carr; L Wright
Journal: In Vitro Cell Dev Biol Date: 1988-10

4. Preparation and antitumor effect of a toxin-linked conjugate targeting vascular endothelial growth factor receptor and urokinase plasminogen activator.

Authors: Ying Xiang; Qiying Li; Dehong Huang; Xianjun Tang; Li Wang; Yang Shi; Wenjun Zhang; Tao Yang; Chunyan Xiao; Jianghong Wang
Journal: Exp Biol Med (Maywood) Date: 2014-08-14

Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue culture.

1. Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects.

2. Kinetic analysis of the effects of glycosaminoglycans and lipoproteins on urokinase-mediated plasminogen activation.

3. Development and characterization of a human cell line from an ovarian mixed Müllerian tumor (carcinosarcoma).

4. Preparation and antitumor effect of a toxin-linked conjugate targeting vascular endothelial growth factor receptor and urokinase plasminogen activator.

5. Release of plasminogen activator from normal and neoplastic endometrium.

Review 6. Tumor invasion and host extracellular matrix.

7. Plasminogen activator secretion by granule neurons in cultures of developing cerebellum.

8. Immunological analysis of plasminogen activators from cultured human cancer cells.

9. Fibrinolysis in cornea and conjunctiva: evidence of two types of activators.

10. Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach.